HOME     ABOUT US     OUR TEAM     TREATMENTS     WHERE DO I START?     FAQS     PRESS ROOM     CONTACT US             



Male Infertility

Infertility in Men - Overview

Determining Causes of Male Infertility

Risk Factors in Male Infertilty

Investigations in Male Infertility

Semen Analysis

Computer Assisted Semen Analysis (CASA)

Treatment of Male Infertility

Varicocele

Male Infertility and IVF

Male Infertility and Lifestyle

Treatment options for Male Infertility

Why You Should Take Male Infertility Seriously?

Azoospermia - Medical Conditions

Test your fertility profile

Assessing the Sperm's Fertilizing Ability

Stress and Male Infertility

Age and Male Infertility

Management of Azoospermia - Investigations

Treatment Options for Azoospermic Men

IMSI : Intracytoplasmic Morphologically-Selected Sperm Injection


Also read..

Introduction to Infertility

Infertility In Women



Azoospermia

Azoospermia may be due to hypothalamic-pituitary failure, primary testicular failure (nonobstructive azoospermia) or obstruction of the genital tract (obstructive azoospermia).

Hypogonadotrophic hypogonadism, which is a condition caused by hypothalamic or pituitary dysfunction, accounts for less than 1% of male factor fertility problems.

It results in a deficiency of LH and FSH, which is associated with failure of spermatogenesis and testosterone secretion.

Primary testicular failure is the most common cause of male infertility due to oligozoospermia and is the cause of nonobstructive azoospermia.

Testicular failure may be due to cryptorchidism, torsion, trauma, orchitis, chromosome disorders (Klinefelter’s syndrome, Y-chromosome microdeletions), systemic disease, radiotherapy or chemotherapy; however, in the majority of cases (66%) the cause is unknown.

The diagnosis is based on reduction in testicular size and elevation of serum FSH levels.

There is no effective treatment to restore fertility in primary testicular failure.

Obstructive azoospermia is uncommon with a prevalence of less than 2%.

The diagnosis is based on normal testis size and normal serum FSH levels. This includes conditions such as congenital bilateral absence of vas deferens (CBAVD). CBAVD is commonly associated with cystic fibrosis mutations or renal tract abnormality (e.g. an absent kidney).

Anejaculation and Retroejaculation

Anejaculation is defined as the total failure of seminal emission into the posterior urethra.
Retrograde ejaculation is the substantial propulsion of seminal fluid from the posterior urethra into the bladder.

Anejaculation is a relatively uncommon occurrence in the general population, and retrograde ejaculation accounts for about 0.3–2.0% of male fertility problems.

Anejaculation and retrograde ejaculation may result from spinal cord injury, transurethral prostatectomy, retroperitoneal lymph node dissection, diabetes mellitus, transverse myelitis, multiple sclerosis or psychogenic (idiopathic) disorders.

With the advent of ICSI, since only a small number of motile spermatozoa is required for a successful fertilisation, both ejaculation disorders can be considered as treatable conditions.

Men undergoingtreatments that cause infertility should be offered the opportunity to cryopreserve semen.

           
  © 2013 OASIS. All Rights Reserved.

 
     
 
Home

About Us

Our Team

Cost Of IVF Treatment

Overseas Patient Facilities

FAQs

Press Room

Contact Us

Sitemap
Treatments

Ovulation Induction

PCOS /PCOD Treatment

In Vitro Fertilization

Surrogacy

Embryo Transfer
Surgical Sperm Recovery

CRYO-Preservation

Sperm Donor Program

Oocyte Donor Program

Embryo Donor Program
Intra Cytoplasmic Sperm Injection

Assisted Embryos Hatching

InVitro Maturation of Oocytes

Intra Uterine Insemination

Computer Assisted Semen
Analysis (CASA)

About Infertility

Female Infertility

Male Infertility

Age and Fertility

Are Women Being Put
at Risk With IVF?